MAPT and myeloid sarcoma: In a mouse model of chronic inflammation‐driven demyelination the levels of insoluble tau positively correlate with axonal loss (Anderson et al., 2008), suggesting that the conversion of soluble to insoluble tau may contribute to axonal pathology in the progressive stage of MS.